Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20448| Title: | Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care. | Austin Authors: | Casan, Joshua Ml;Barraclough, Allison ;Shortt, Jake;Hawkes, Eliza A | Affiliation: | School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Haematology Department, Monash Health, Melbourne, Victoria, Australia |
Issue Date: | Mar-2019 | Publication information: | The Lancet. Haematology 2019; 6(3): e119 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/20448 | DOI: | 10.1016/S2352-3026(19)30013-4 | ORCID: | 0000-0002-0376-2559 | Journal: | The Lancet. Haematology | PubMed URL: | 30824036 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.